Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Targeting ERBB Receptors to Inhibit Metastasis: Old Hopes and New Certainties promotion: free to download

Volume:9   Issue: 1
Pp: 1-18
Adriano Angelucci
DOI: 10.2174/156800909787314048

Emerging Treatments in Acute Lymphoblastic Leukemia promotion: free to download

Volume:9   Issue: 1
Pp: 19-31
R. Crazzolara and L. Bendall
DOI: 10.2174/156800909787314057

The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy promotion: free to download

Volume:9   Issue: 1
Pp: 32-71
Salvatore Ulisse, Enke Baldini, Salvatore Sorrenti and Massimino D'Armiento
DOI: 10.2174/156800909787314002

The Role of Downstream Signaling Pathways of the Epidermal Growth Factor Receptor for Artesunates Activity in Cancer Cells promotion: free to download

Volume:9   Issue: 1
Pp: 72-80
V. Badireenath Konkimalla, James A. McCubrey and Thomas Efferth
DOI: 10.2174/156800909787314020

TNF-α Induction by Nickel Compounds is Specific Through ERKs/AP-1- Dependent Pathway in Human Bronchial Epithelial Cells promotion: free to download

Volume:9   Issue: 1
Pp: 81-90
Jin Ding, Yi Huang, Beifang Ning, Wenfeng Gong, Jingxia Li, Hongyang Wang, Chang-Yan Chen and Chuanshu Huang
DOI: 10.2174/156800909787313995

The Changing Face of HDAC Inhibitor Depsipeptide promotion: free to download

Volume:9   Issue: 1
Pp: 91-100
Wen Zhou and Wei-Guo Zhu
DOI: 10.2174/156800909787314039

Fanconi Anemia Proteins, DNA Interstrand Crosslink Repair Pathways, and Cancer Therapy promotion: free to download

Volume:9   Issue: 1
Pp: 101-117
Paul R. Andreassen and Keqin Ren
DOI: 10.2174/156800909787314011